Stent news from FiercePharma
News
J&J win in patent suit
Johnson and Johnson received some happy news yesterday when a federal judge awarded its cardiac device unit $1.2 billion in a longstanding battle between the megacompany, Boston Scientific and... Read more...
Boston Scientific's stent data flawed
Boston Scientific's new heart stent, awaiting approval for U.S. sales, is backed by flawed research despite the company's claims of success in a clinical trial, according to a Wall Street Journal... Read more...
FDA wants to lengthen stent testing
Looking for hard evidence that the FDA is tightening approval standards? Here it is. The agency today proposed tougher clinical trial guidelines for drug-coated stents. Rather than letting new... Read more...
Burning query: Will my Fidelis lead fail?
A shocking problem: Patients are trying to figure out whether to live with a recalled Medtronic defibrillator lead known as Fidelis, or to undergo lengthy, expensive surgery to have their devices... Read more...
Abbott Labs to cut 1,200 jobs
A new entrant into the layoff club is Abbott Laboratories, which says it's cutting 1,200 jobs in Ireland and... Read more...
Boston Sci settles more Guidant cases
How's about $45 million more? Boston Scientific says it's bolstering its fund for Read more...
Docs reconsider drug-coated stents
Well, maybe drug-coated stents aren't so bad after all. Some doctors are now saying that the medical community Read more...
Boston Scientific hands out pink slips
Look for Boston Scientific workers at the nearest job fair. The device maker's previously announced job cuts--Read more...
Study: Coated stents aren't cost-effective
If drug-eluting stents were on the shelves at Costco, most value-conscious customers wouldn't buy. A new Swiss study has found that the coated stents aren't cost-effective for most patients--and... Read more...
Why didn't Medtronic recall sooner?
Big cardiac clinics across the country stopped using Medtronic's Fidelis defibrillator lead in early February because they considered it unsafe. So why did the company Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
